US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Atea Pharmaceuticals, Inc.

4.15

+0.13003.23%

Post-market: 4.150.00000.00%16:10 EST

Volume:323.80K

Turnover:1.34M

Market Cap:324.23M

PE:-2.35

High:4.17

Open:4.05

Low:3.91

Close:4.02

52wk High:4.34

52wk Low:2.46

Shares:78.13M

Float Shares:60.01M

Volume Ratio:0.41

T/O Rate:0.54%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7696

EPS(LYR):-1.9983

ROE:-37.98%

ROA:-23.86%

PB:1.03

PE(LYR):-2.08

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Atea Pharmaceuticals (AVIR) and Penumbra (PEN)

Atea Pharmaceuticals Unveils Antiviral Pipeline Progress and Phase 3 HCV Trial Updates

Atea Pharmaceuticals Outlines 2026 Strategy with Planned Phase 3 HCV Readouts, Initiation of HEV Phase 1 Trial, and Evaluation of Global Commercialization Options

Atea Pharmaceuticals Presents 2026 Strategic Priorities at J.P. Morgan Healthcare Conference

Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44TH Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS

Atea Pharmaceuticals Completes Patient Enrollment In North American Phase 3 Trial Evaluating Regimen Of Bemnifosbuvir And Ruzasvir For Treatment Of Hepatitis C Virus

Atea Pharmaceuticals Completes Enrollment in Phase 3 HCV Trial of Bemnifosbuvir and Ruzasvir

Atea Pharmaceuticals Inc - C-Beyond Topline Results Expected Mid-2026

THOMSON REUTERS

Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

THOMSON REUTERS

Nano Dimension And 2 Other Penny Stocks With Promising Potential

Simply Wall St.

Atea Pharmaceuticals to Present at Evercore Healthcare Conference

3 Promising Penny Stocks With Market Caps As Low As $200M

Simply Wall St.

Atea Pharmaceuticals Advances Antiviral Programs with New Data

Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Announces Progress in Hepatitis C and E Programs

Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Atea Pharmaceuticals announces presentation of data on BEM, RZR

Atea Pharmaceuticals Unveils Promising Phase 2 Data for Bemnifosbuvir and Ruzasvir Hepatitis C Treatment

Atea Pharmaceuticals Inc. to Report Third Quarter 2025 Financial Results

Atea Pharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview

Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVIR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"AVIR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVIR\",,,,,undefined,":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":4.15,"timestamp":1770411600000,"preClose":4.02,"halted":0,"volume":323799,"hourTrading":{"tag":"盘后","latestPrice":4.15,"preClose":4.15,"latestTime":"16:10 EST","volume":3561,"amount":14778.15,"timestamp":1770412204705,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03233830845771164,"floatShares":60009700,"shares":78126796,"eps":-1.769595,"marketStatus":"Market Closed","change":0.13,"latestTime":"02-06 16:00:00 EST","open":4.05,"high":4.172,"low":3.91,"amount":1338071.787724,"amplitude":0.065174,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769595,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1604030400000,"exchange":"NASDAQ","adjPreClose":4.02,"preHourTrading":{"tag":"盘前","latestPrice":4.1,"preClose":4.02,"latestTime":"07:00 EST","volume":1,"amount":4.1,"timestamp":1770379208294,"change":0.08,"changeRate":0.0199,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.15,"preClose":4.15,"latestTime":"16:10 EST","volume":3561,"amount":14778.15,"timestamp":1770412204705,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.41143968496539857,"impliedVol":1.3511,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVIR\",,,,,undefined,":{"symbol":"AVIR","floatShares":60009700,"roa":"-23.86%","roe":"-37.98%","lyrEps":-1.998285,"volumeRatio":0.41143968496539857,"shares":78126796,"dividePrice":0,"high":4.172,"amplitude":0.065174,"preClose":4.02,"low":3.91,"week52Low":2.455,"pbRate":"1.03","psRate":"1.69","week52High":4.3399,"institutionHeld":0.4276,"latestPrice":4.15,"eps":-1.769595,"divideRate":0,"volume":323799,"delay":0,"ttmEps":-1.769595,"open":4.05,"prevYearClose":3.57,"prevWeekClose":4.24,"prevMonthClose":4.24,"prevQuarterClose":3.57,"fiveDayClose":4.24,"twentyDayClose":3.61,"sixtyDayClose":3.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVIR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"AVIR","fiscalQuarterEnding":"2025/09","expectedEps":-0.46,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.53},{"market":"US","date":"2025-08-07","symbol":"AVIR","fiscalQuarterEnding":"2025/06","expectedEps":-0.46,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2025-05-12","symbol":"AVIR","fiscalQuarterEnding":"2025/03","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2025-03-06","symbol":"AVIR","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-07","symbol":"AVIR","fiscalQuarterEnding":"2024/09","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVIR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVIR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1764219600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVIR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVIR","date":"2026-02-06","current":-2.345169,"percent":0.271595,"low":-466.703742,"twenty":-2.385456,"median":-1.645298,"eighty":23.329559,"high":114.976269,"avg":-1.14101,"sd":65.400481,"marketCap":314069719},"quantilePoints":[{"date":"2021-02-12","current":-186.912332,"twenty":-187.630723,"median":-154.457973,"eighty":-95.135484,"marketCap":6777067342},{"date":"2021-02-19","current":-190.558068,"twenty":-189.772842,"median":-158.862185,"eighty":-95.217512,"marketCap":6909254441},{"date":"2021-02-26","current":-171.71417,"twenty":-189.772842,"median":-159.511523,"eighty":-96.684921,"marketCap":6226012372},{"date":"2021-03-05","current":-136.669532,"twenty":-188.951987,"median":-160.201207,"eighty":-99.647082,"marketCap":4955363881},{"date":"2021-03-12","current":-154.624782,"twenty":-188.240537,"median":-158.890417,"eighty":-101.734266,"marketCap":5606385344},{"date":"2021-03-19","current":-177.934707,"twenty":-187.800115,"median":-159.27838,"eighty":-104.710098,"marketCap":6451556610},{"date":"2021-03-26","current":-137.079677,"twenty":-187.140095,"median":-158.946881,"eighty":-108.114304,"marketCap":4970234929},{"date":"2021-04-01","current":-436.925398,"twenty":-188.274415,"median":-159.045237,"eighty":-110.534161,"marketCap":4783022327},{"date":"2021-04-09","current":-427.100056,"twenty":-190.548954,"median":-160.935243,"eighty":-115.451347,"marketCap":4675464309},{"date":"2021-04-16","current":-339.654512,"twenty":-191.931363,"median":-165.157949,"eighty":-119.324942,"marketCap":3718197948},{"date":"2021-04-23","current":-275.185154,"twenty":-195.768604,"median":-167.331823,"eighty":-122.091144,"marketCap":3012451876},{"date":"2021-04-30","current":-186.757076,"twenty":-199.196041,"median":-171.312553,"eighty":-123.440067,"marketCap":2044429713},{"date":"2021-05-07","current":-161.135608,"twenty":-197.99537,"median":-168.007959,"eighty":-124.055285,"marketCap":1763951496},{"date":"2021-05-14","current":79.797223,"twenty":-196.113259,"median":-166.426176,"eighty":-123.440067,"marketCap":1895503226},{"date":"2021-05-21","current":78.125347,"twenty":-195.768604,"median":-164.402964,"eighty":-110.534161,"marketCap":1855789496},{"date":"2021-05-28","current":71.124369,"twenty":-194.157991,"median":-160.979594,"eighty":-99.246051,"marketCap":1689488253},{"date":"2021-06-04","current":74.990581,"twenty":-192.938363,"median":-159.511523,"eighty":-95.039783,"marketCap":1781326253},{"date":"2021-06-11","current":82.757835,"twenty":-192.37372,"median":-159.183468,"eighty":-82.507565,"marketCap":1965829623},{"date":"2021-06-18","current":81.469098,"twenty":-191.978471,"median":-158.890417,"eighty":-77.722536,"marketCap":1935216956},{"date":"2021-06-25","current":82.931989,"twenty":-191.742933,"median":-157.410556,"eighty":-69.975347,"marketCap":1969966469},{"date":"2021-07-02","current":81.08596,"twenty":-190.990999,"median":-154.624782,"eighty":67.989602,"marketCap":1926115893},{"date":"2021-07-09","current":80.075869,"twenty":-190.877549,"median":-153.804491,"eighty":71.451777,"marketCap":1902122181},{"date":"2021-07-16","current":79.762392,"twenty":-190.616292,"median":-149.016908,"eighty":72.482768,"marketCap":1894675857},{"date":"2021-07-23","current":87.459985,"twenty":-190.521611,"median":-146.01173,"eighty":76.523133,"marketCap":2077524488},{"date":"2021-07-30","current":87.21617,"twenty":-190.129695,"median":-138.834187,"eighty":78.278602,"marketCap":2071732902},{"date":"2021-08-06","current":108.532582,"twenty":-189.511691,"median":-136.601174,"eighty":79.811155,"marketCap":2578082956},{"date":"2021-08-13","current":64.910668,"twenty":-188.522858,"median":-135.134867,"eighty":80.20126,"marketCap":2290437846},{"date":"2021-08-20","current":69.578982,"twenty":-188.17278,"median":-133.639014,"eighty":79.908681,"marketCap":2455163951},{"date":"2021-08-27","current":73.543529,"twenty":-187.46133,"median":-129.708455,"eighty":79.811155,"marketCap":2595056974},{"date":"2021-09-03","current":67.819567,"twenty":-186.988253,"median":-125.64118,"eighty":79.769358,"marketCap":2393081248},{"date":"2021-09-10","current":67.092343,"twenty":-186.819178,"median":-123.385381,"eighty":79.6579,"marketCap":2367420398},{"date":"2021-09-17","current":61.532592,"twenty":-186.754529,"median":-116.674948,"eighty":79.170269,"marketCap":2171239057},{"date":"2021-09-24","current":75.396779,"twenty":-185.83684,"median":-107.184641,"eighty":78.431857,"marketCap":2660450755},{"date":"2021-10-01","current":98.550675,"twenty":-184.365164,"median":-99.847598,"eighty":79.353564,"marketCap":3477459123},{"date":"2021-10-08","current":93.976197,"twenty":-183.486247,"median":-95.199284,"eighty":79.950478,"marketCap":3316044096},{"date":"2021-10-15","current":92.146406,"twenty":-182.808676,"median":-92.009265,"eighty":81.232249,"marketCap":3251478085},{"date":"2021-10-22","current":29.86313,"twenty":-182.369073,"median":-82.507565,"eighty":81.232249,"marketCap":1053750408},{"date":"2021-10-29","current":27.306114,"twenty":-181.597122,"median":-78.679542,"eighty":81.099892,"marketCap":963523546},{"date":"2021-11-05","current":25.359029,"twenty":-180.96794,"median":-70.955139,"eighty":80.856077,"marketCap":894818688},{"date":"2021-11-12","current":38.198876,"twenty":-179.102829,"median":-70.055098,"eighty":80.32665,"marketCap":944047012},{"date":"2021-11-19","current":27.2705,"twenty":-177.005044,"median":-64.575101,"eighty":79.950478,"marketCap":673963140},{"date":"2021-11-26","current":27.371377,"twenty":-176.330583,"median":25.218276,"eighty":79.83902,"marketCap":676456222},{"date":"2021-12-03","current":27.102371,"twenty":-176.111839,"median":25.704021,"eighty":79.783291,"marketCap":669808003},{"date":"2021-12-10","current":26.799739,"twenty":-175.627494,"median":26.093598,"eighty":79.69273,"marketCap":662328758},{"date":"2021-12-17","current":28.750034,"twenty":-174.603768,"median":26.564359,"eighty":79.431789,"marketCap":710528341},{"date":"2021-12-23","current":30.633077,"twenty":-173.693594,"median":26.850178,"eighty":79.136017,"marketCap":757065870},{"date":"2021-12-31","current":30.061439,"twenty":-173.535454,"median":27.03512,"eighty":78.738368,"marketCap":742938406},{"date":"2022-01-07","current":25.690089,"twenty":-172.807662,"median":27.068745,"eighty":77.999956,"marketCap":634904857},{"date":"2022-01-14","current":24.546813,"twenty":-172.137986,"median":26.900617,"eighty":77.393902,"marketCap":606649929},{"date":"2022-01-21","current":21.654996,"twenty":-171.736956,"median":26.766114,"eighty":76.975933,"marketCap":535181581},{"date":"2022-01-28","current":22.865524,"twenty":-171.71417,"median":26.328978,"eighty":76.662456,"marketCap":565098564},{"date":"2022-02-04","current":23.000027,"twenty":-171.312553,"median":26.093598,"eighty":76.488302,"marketCap":568422673},{"date":"2022-02-11","current":22.66377,"twenty":-168.09122,"median":25.807779,"eighty":75.396779,"marketCap":560112400},{"date":"2022-02-18","current":19.906456,"twenty":-167.924698,"median":25.690089,"eighty":75.396779,"marketCap":491968161},{"date":"2022-02-25","current":21.419616,"twenty":-166.976098,"median":25.359029,"eighty":75.378012,"marketCap":529364390},{"date":"2022-03-04","current":3.948735,"twenty":-166.48873,"median":24.788709,"eighty":75.073047,"marketCap":478547148},{"date":"2022-03-11","current":3.976204,"twenty":-166.354602,"median":24.479561,"eighty":74.992061,"marketCap":481876171},{"date":"2022-03-18","current":4.862094,"twenty":-165.393701,"median":23.807046,"eighty":74.851258,"marketCap":589237184},{"date":"2022-03-25","current":4.745349,"twenty":-163.949973,"median":23.269033,"eighty":74.398458,"marketCap":575088833},{"date":"2022-04-01","current":4.875829,"twenty":-161.638082,"median":23.117718,"eighty":74.106492,"marketCap":590901696},{"date":"2022-04-08","current":4.573665,"twenty":-161.010797,"median":23.000027,"eighty":73.646748,"marketCap":554282436},{"date":"2022-04-14","current":4.525593,"twenty":-160.926372,"median":22.865524,"eighty":73.205722,"marketCap":548456644},{"date":"2022-04-22","current":4.044878,"twenty":-160.06327,"median":22.058506,"eighty":72.410188,"marketCap":490198730},{"date":"2022-04-29","current":4.032693,"twenty":-159.488323,"median":21.654996,"eighty":71.812079,"marketCap":488722059},{"date":"2022-05-06","current":3.792243,"twenty":-159.382162,"median":21.503681,"eighty":71.654826,"marketCap":459581902},{"date":"2022-05-13","current":12.540245,"twenty":-159.155821,"median":20.915229,"eighty":71.605033,"marketCap":606947838},{"date":"2022-05-20","current":12.884284,"twenty":-158.986223,"median":20.141837,"eighty":71.560583,"marketCap":623599356},{"date":"2022-05-27","current":14.071221,"twenty":-158.913003,"median":19.502947,"eighty":71.524315,"marketCap":681047094},{"date":"2022-06-03","current":13.417546,"twenty":-158.867831,"median":13.555162,"eighty":71.479642,"marketCap":649409209},{"date":"2022-06-10","current":13.27993,"twenty":-158.508321,"median":13.709979,"eighty":71.312455,"marketCap":642748602},{"date":"2022-06-17","current":11.181288,"twenty":-157.53242,"median":13.53796,"eighty":70.650671,"marketCap":541174341},{"date":"2022-06-24","current":12.265013,"twenty":-156.71581,"median":13.27993,"eighty":69.928889,"marketCap":593626623},{"date":"2022-07-01","current":12.557447,"twenty":-156.024233,"median":12.93589,"eighty":69.874563,"marketCap":607780414},{"date":"2022-07-08","current":13.606767,"twenty":-154.624782,"median":12.93589,"eighty":69.837029,"marketCap":658567544},{"date":"2022-07-15","current":13.933605,"twenty":-154.533639,"median":13.27993,"eighty":69.719735,"marketCap":674386487},{"date":"2022-07-22","current":13.761585,"twenty":-153.804491,"median":13.443349,"eighty":69.602441,"marketCap":666060728},{"date":"2022-07-29","current":14.105625,"twenty":-152.114706,"median":13.555162,"eighty":69.578982,"marketCap":682712246},{"date":"2022-08-05","current":15.120542,"twenty":-149.194038,"median":13.675575,"eighty":69.156722,"marketCap":731834224},{"date":"2022-08-12","current":45.098857,"twenty":-148.839779,"median":13.813191,"eighty":68.570251,"marketCap":700204851},{"date":"2022-08-19","current":44.187227,"twenty":-148.362663,"median":13.881999,"eighty":68.523333,"marketCap":686050888},{"date":"2022-08-26","current":41.988591,"twenty":-146.01173,"median":13.933605,"eighty":68.030697,"marketCap":651914861},{"date":"2022-09-02","current":39.95083,"twenty":-143.642002,"median":14.019615,"eighty":67.989602,"marketCap":620276592},{"date":"2022-09-09","current":42.256717,"twenty":-141.199359,"median":14.06262,"eighty":67.909876,"marketCap":656077791},{"date":"2022-09-16","current":35.98256,"twenty":-137.781481,"median":14.088423,"eighty":67.833642,"marketCap":558665226},{"date":"2022-09-23","current":31.10266,"twenty":-136.751561,"median":14.217438,"eighty":67.500527,"marketCap":482899897},{"date":"2022-09-30","current":30.512782,"twenty":-136.614846,"median":14.535674,"eighty":67.27063,"marketCap":473741451},{"date":"2022-10-07","current":28.957649,"twenty":-135.731607,"median":14.862512,"eighty":67.176794,"marketCap":449596456},{"date":"2022-10-14","current":28.15327,"twenty":-135.514215,"median":19.872831,"eighty":67.106418,"marketCap":437107665},{"date":"2022-10-21","current":28.528647,"twenty":-134.907259,"median":20.562159,"eighty":66.974213,"marketCap":442935767},{"date":"2022-10-28","current":31.638913,"twenty":-134.153974,"median":21.38599,"eighty":66.781304,"marketCap":491225757},{"date":"2022-11-04","current":32.389666,"twenty":-133.711929,"median":21.604558,"eighty":65.670736,"marketCap":502881962},{"date":"2022-11-11","current":12.077105,"twenty":-132.636436,"median":21.38599,"eighty":65.403305,"marketCap":430597093},{"date":"2022-11-18","current":10.909106,"twenty":-131.930075,"median":20.562159,"eighty":65.103031,"marketCap":388953274},{"date":"2022-11-25","current":10.955826,"twenty":-129.286916,"median":19.889643,"eighty":64.999812,"marketCap":390619026},{"date":"2022-12-02","current":11.212786,"twenty":-126.766801,"median":15.120542,"eighty":64.938819,"marketCap":399780667},{"date":"2022-12-09","current":10.255027,"twenty":-125.869038,"median":14.552876,"eighty":64.150601,"marketCap":365632735},{"date":"2022-12-16","current":10.768946,"twenty":-124.451759,"median":14.260443,"eighty":62.377111,"marketCap":383956015},{"date":"2022-12-23","current":10.722226,"twenty":-123.494753,"median":14.097024,"eighty":61.180709,"marketCap":382290263},{"date":"2022-12-30","current":11.236146,"twenty":-122.738263,"median":14.071221,"eighty":55.100568,"marketCap":400613543},{"date":"2023-01-06","current":10.979186,"twenty":-121.156924,"median":14.045418,"eighty":46.278613,"marketCap":391451903},{"date":"2023-01-13","current":11.516465,"twenty":-117.898548,"median":13.950807,"eighty":46.053387,"marketCap":410608060},{"date":"2023-01-20","current":11.446386,"twenty":-114.635614,"median":13.899201,"eighty":46.010486,"marketCap":408109431},{"date":"2023-01-27","current":10.745586,"twenty":-109.508798,"median":13.856196,"eighty":45.903236,"marketCap":383123139},{"date":"2023-02-03","current":10.535347,"twenty":-107.184641,"median":13.761585,"eighty":45.474234,"marketCap":375627251},{"date":"2023-02-10","current":9.834548,"twenty":-103.060402,"median":13.659535,"eighty":45.098857,"marketCap":350640960},{"date":"2023-02-17","current":9.927987,"twenty":-100.850175,"median":13.555162,"eighty":44.937981,"marketCap":353972465},{"date":"2023-02-24","current":8.573109,"twenty":-99.246051,"median":13.469152,"eighty":44.466079,"marketCap":305665635},{"date":"2023-03-03","current":-2.538161,"twenty":-95.964888,"median":13.331536,"eighty":44.219402,"marketCap":294195756},{"date":"2023-03-10","current":-2.401547,"twenty":-95.208398,"median":12.953092,"eighty":44.144327,"marketCap":278360857},{"date":"2023-03-17","current":-2.710728,"twenty":-95.071683,"median":12.884284,"eighty":43.9191,"marketCap":314197733},{"date":"2023-03-24","current":-2.157078,"twenty":-94.511151,"median":12.695062,"eighty":43.736775,"marketCap":250024722},{"date":"2023-03-31","current":-2.408737,"twenty":-90.587427,"median":12.600452,"eighty":43.532999,"marketCap":279194272},{"date":"2023-04-05","current":-2.415927,"twenty":-89.411678,"median":12.557447,"eighty":43.425749,"marketCap":280027688},{"date":"2023-04-14","current":-2.423117,"twenty":-86.44496,"median":12.505841,"eighty":43.221972,"marketCap":280861104},{"date":"2023-04-21","current":-2.344024,"twenty":-81.331815,"median":12.282215,"eighty":42.953846,"marketCap":271693531},{"date":"2023-04-28","current":-2.379976,"twenty":-79.258302,"median":12.230609,"eighty":42.578469,"marketCap":275860609},{"date":"2023-05-05","current":-2.396017,"twenty":-78.702328,"median":12.100465,"eighty":42.149467,"marketCap":277719925},{"date":"2023-05-12","current":-2.525658,"twenty":-78.228382,"median":11.92588,"eighty":41.83844,"marketCap":276051937},{"date":"2023-05-19","current":-2.739309,"twenty":-75.015577,"median":11.731751,"eighty":41.570314,"marketCap":299403763},{"date":"2023-05-26","current":-3.53287,"twenty":-70.863995,"median":11.512296,"eighty":41.205661,"marketCap":386139115},{"date":"2023-06-02","current":-3.113198,"twenty":-70.608794,"median":11.483414,"eighty":40.647959,"marketCap":340269458},{"date":"2023-06-09","current":-3.258176,"twenty":-70.102948,"median":11.446386,"eighty":40.186782,"marketCap":356115339},{"date":"2023-06-16","current":-3.166611,"twenty":-69.546973,"median":11.318087,"eighty":40.036631,"marketCap":346107414},{"date":"2023-06-23","current":-2.983482,"twenty":-67.833477,"median":11.259506,"eighty":39.95083,"marketCap":326091564},{"date":"2023-06-30","current":-2.861395,"twenty":-65.226776,"median":11.224466,"eighty":39.95083,"marketCap":312747663},{"date":"2023-07-07","current":-2.75457,"twenty":-28.146626,"median":11.197037,"eighty":39.182114,"marketCap":301071750},{"date":"2023-07-14","current":-2.861395,"twenty":-3.801459,"median":11.166066,"eighty":38.537448,"marketCap":312747663},{"date":"2023-07-21","current":-2.807983,"twenty":-3.706843,"median":11.072626,"eighty":38.299055,"marketCap":306909707},{"date":"2023-07-28","current":-2.540919,"twenty":-3.6107,"median":11.002546,"eighty":38.198876,"marketCap":277719925},{"date":"2023-08-04","current":-2.640114,"twenty":-3.548131,"median":10.967506,"eighty":37.383889,"marketCap":288561844},{"date":"2023-08-11","current":-2.663513,"twenty":-3.496244,"median":10.955826,"eighty":36.776214,"marketCap":282723888},{"date":"2023-08-18","current":-2.67137,"twenty":-3.448936,"median":10.920786,"eighty":36.282862,"marketCap":283557881},{"date":"2023-08-25","current":-2.639942,"twenty":-3.383314,"median":10.909106,"eighty":35.775559,"marketCap":280221906},{"date":"2023-09-01","current":-2.639942,"twenty":-3.29938,"median":10.885746,"eighty":34.557553,"marketCap":280221906},{"date":"2023-09-08","current":-2.577086,"twenty":-3.262754,"median":10.803986,"eighty":33.730299,"marketCap":273549956},{"date":"2023-09-15","current":-2.577086,"twenty":-3.258176,"median":10.768946,"eighty":33.569423,"marketCap":273549956},{"date":"2023-09-21","current":-2.498516,"twenty":-3.22155,"median":10.768946,"eighty":33.151146,"marketCap":265210018},{"date":"2023-10-06","current":-2.364948,"twenty":-3.197133,"median":10.768946,"eighty":32.872294,"marketCap":251032124},{"date":"2023-10-09","current":-2.33352,"twenty":-3.191029,"median":10.768946,"eighty":32.797219,"marketCap":247696149},{"date":"2023-10-17","current":-2.357091,"twenty":-3.184924,"median":10.757266,"eighty":32.722143,"marketCap":250198131},{"date":"2023-11-01","current":-2.553515,"twenty":-3.172715,"median":10.733906,"eighty":32.571992,"marketCap":271047975},{"date":"2023-11-10","current":-1.900308,"twenty":-3.162033,"median":10.710546,"eighty":32.464742,"marketCap":249364137},{"date":"2023-11-17","current":-1.850265,"twenty":-3.149824,"median":10.675507,"eighty":32.429404,"marketCap":242797342},{"date":"2023-11-24","current":-1.812115,"twenty":-3.14372,"median":10.628787,"eighty":32.407954,"marketCap":237791212},{"date":"2023-12-01","current":-1.901132,"twenty":-3.140668,"median":10.582067,"eighty":32.303866,"marketCap":249472183},{"date":"2023-12-08","current":-1.86934,"twenty":-3.129985,"median":10.535347,"eighty":32.153715,"marketCap":245300408},{"date":"2023-12-15","current":-1.894773,"twenty":-3.117777,"median":10.42211,"eighty":31.956565,"marketCap":248637828},{"date":"2023-12-22","current":-1.996506,"twenty":-3.10099,"median":10.266707,"eighty":31.681026,"marketCap":261987510},{"date":"2023-12-29","current":-1.971073,"twenty":-3.082677,"median":10.255027,"eighty":31.638913,"marketCap":258650090},{"date":"2024-01-05","current":-1.971073,"twenty":-3.064364,"median":10.231667,"eighty":31.638913,"marketCap":258650090},{"date":"2024-01-12","current":-2.276271,"twenty":-3.047577,"median":10.184947,"eighty":31.478037,"marketCap":298699136},{"date":"2024-01-19","current":-2.269913,"twenty":-3.035369,"median":10.004174,"eighty":31.263536,"marketCap":297864781},{"date":"2024-01-26","current":-2.397079,"twenty":-3.006373,"median":9.834548,"eighty":31.085409,"marketCap":314551884},{"date":"2024-02-02","current":-2.683202,"twenty":-2.946856,"median":9.577588,"eighty":31.055333,"marketCap":352097864},{"date":"2024-02-09","current":-2.708636,"twenty":-2.891917,"median":9.390708,"eighty":30.990254,"marketCap":355435285},{"date":"2024-02-16","current":-2.676844,"twenty":-2.888865,"median":8.806709,"eighty":30.896513,"marketCap":351263509},{"date":"2024-02-23","current":-2.562395,"twenty":-2.882761,"median":6.674963,"eighty":30.855984,"marketCap":336245117},{"date":"2024-03-01","current":-2.668137,"twenty":-2.882761,"median":4.999441,"eighty":30.721892,"marketCap":362749188},{"date":"2024-03-08","current":-2.525754,"twenty":-2.873604,"median":4.937635,"eighty":30.686879,"marketCap":343391343},{"date":"2024-03-15","current":-2.38337,"twenty":-2.861395,"median":4.862094,"eighty":30.626352,"marketCap":324033498},{"date":"2024-03-22","current":-2.538135,"twenty":-2.859869,"median":4.779686,"eighty":30.582117,"marketCap":345074634},{"date":"2024-03-28","current":-2.476229,"twenty":-2.853765,"median":4.714446,"eighty":30.512782,"marketCap":336658180},{"date":"2024-04-05","current":-2.38337,"twenty":-2.838504,"median":4.601134,"eighty":30.431323,"marketCap":324033498},{"date":"2024-04-12","current":-2.38337,"twenty":-2.823244,"median":4.553063,"eighty":30.405531,"marketCap":324033498},{"date":"2024-04-19","current":-2.290512,"twenty":-2.823244,"median":4.525593,"eighty":30.351906,"marketCap":311408816},{"date":"2024-04-26","current":-2.284321,"twenty":-2.815613,"median":4.46722,"eighty":30.08378,"marketCap":310567171},{"date":"2024-05-03","current":-2.372639,"twenty":-2.815613,"median":4.353909,"eighty":30.061439,"marketCap":322574473},{"date":"2024-05-10","current":-2.434588,"twenty":-2.807983,"median":4.312705,"eighty":30.030154,"marketCap":330996783},{"date":"2024-05-17","current":-1.904126,"twenty":-2.800352,"median":4.257766,"eighty":29.976529,"marketCap":311625470},{"date":"2024-05-24","current":-1.89898,"twenty":-2.792722,"median":4.22424,"eighty":29.910048,"marketCap":310783239},{"date":"2024-05-31","current":-1.85781,"twenty":-2.783638,"median":4.207069,"eighty":29.872514,"marketCap":304045391},{"date":"2024-06-07","current":-1.955589,"twenty":-2.778242,"median":4.154756,"eighty":29.844363,"marketCap":320047780},{"date":"2024-06-14","current":-1.904126,"twenty":-2.777461,"median":4.051745,"eighty":29.76091,"marketCap":311625470},{"date":"2024-06-21","current":-1.76003,"twenty":-2.777461,"median":4.044878,"eighty":29.688214,"marketCap":288043002},{"date":"2024-06-28","current":-1.739445,"twenty":-2.777461,"median":4.032693,"eighty":29.668025,"marketCap":284674078},{"date":"2024-07-05","current":-1.687982,"twenty":-2.777461,"median":3.976204,"eighty":29.559513,"marketCap":276251768},{"date":"2024-07-12","current":-1.734299,"twenty":-2.763867,"median":3.884237,"eighty":29.461726,"marketCap":283831847},{"date":"2024-07-15","current":-1.765176,"twenty":-2.759336,"median":3.860943,"eighty":29.451001,"marketCap":288885233},{"date":"2024-08-02","current":-1.868102,"twenty":-2.754805,"median":3.826593,"eighty":29.440276,"marketCap":305729853},{"date":"2024-08-09","current":-1.678875,"twenty":-2.75457,"median":3.661713,"eighty":29.440276,"marketCap":295477000},{"date":"2024-08-16","current":-1.793998,"twenty":-2.753144,"median":-1.61172,"eighty":29.220795,"marketCap":315738280},{"date":"2024-08-23","current":-1.813185,"twenty":-2.746785,"median":-1.641665,"eighty":29.220795,"marketCap":319115160},{"date":"2024-08-30","current":-1.813185,"twenty":-2.742082,"median":-1.683428,"eighty":29.17215,"marketCap":319115160},{"date":"2024-09-06","current":-1.736437,"twenty":-2.739864,"median":-1.687982,"eighty":29.086853,"marketCap":305607640},{"date":"2024-09-13","current":-1.760421,"twenty":-2.724943,"median":-1.693128,"eighty":29.001437,"marketCap":309828740},{"date":"2024-09-20","current":-1.832372,"twenty":-2.712853,"median":-1.726843,"eighty":28.985414,"marketCap":322492040},{"date":"2024-09-27","current":-1.650094,"twenty":-2.709176,"median":-1.703421,"eighty":28.963202,"marketCap":290411680},{"date":"2024-10-04","current":-1.59733,"twenty":-2.708666,"median":-1.687982,"eighty":28.871848,"marketCap":281125260},{"date":"2024-10-11","current":-1.602127,"twenty":-2.708636,"median":-1.687982,"eighty":28.797008,"marketCap":281969480},{"date":"2024-10-18","current":-1.789201,"twenty":-2.688289,"median":-1.687982,"eighty":28.756759,"marketCap":314894060},{"date":"2024-10-25","current":-1.621314,"twenty":-2.682118,"median":-1.687982,"eighty":28.750034,"marketCap":285346360},{"date":"2024-10-31","current":-1.573346,"twenty":-2.680275,"median":-1.687982,"eighty":28.629674,"marketCap":276904160},{"date":"2024-11-08","current":-1.668975,"twenty":-2.679227,"median":-1.678875,"eighty":28.536962,"marketCap":290411680},{"date":"2024-11-15","current":-1.606684,"twenty":-2.677797,"median":-1.672543,"eighty":28.464296,"marketCap":279572725},{"date":"2024-11-22","current":-1.57756,"twenty":-2.676844,"median":-1.669129,"eighty":28.421396,"marketCap":274504941},{"date":"2024-11-29","current":-1.660079,"twenty":-2.674654,"median":-1.659884,"eighty":28.357046,"marketCap":288863661},{"date":"2024-12-06","current":-1.422231,"twenty":-2.671016,"median":-1.660079,"eighty":28.23907,"marketCap":247476762},{"date":"2024-12-13","current":-1.431939,"twenty":-2.669546,"median":-1.652631,"eighty":28.185445,"marketCap":249166024},{"date":"2024-12-20","current":-1.519312,"twenty":-2.666287,"median":-1.650094,"eighty":28.152215,"marketCap":264369374},{"date":"2024-12-27","current":-1.596976,"twenty":-2.661942,"median":-1.641665,"eighty":28.145941,"marketCap":277883464},{"date":"2025-01-03","current":-1.660079,"twenty":-2.655656,"median":-1.640501,"eighty":28.127174,"marketCap":288863661},{"date":"2025-01-10","current":-1.621246,"twenty":-2.655656,"median":-1.640501,"eighty":28.070873,"marketCap":282106617},{"date":"2025-01-17","current":-1.616392,"twenty":-2.649327,"median":-1.635704,"eighty":27.992672,"marketCap":281261986},{"date":"2025-01-24","current":-1.50475,"twenty":-2.646707,"median":-1.633539,"eighty":27.93629,"marketCap":261835482},{"date":"2025-01-31","current":-1.451355,"twenty":-2.645438,"median":-1.630955,"eighty":27.830492,"marketCap":252544546},{"date":"2025-02-07","current":-1.50475,"twenty":-2.64209,"median":-1.626106,"eighty":27.755914,"marketCap":261835482},{"date":"2025-02-14","current":-1.509604,"twenty":-2.640114,"median":-1.621314,"eighty":27.677227,"marketCap":262680113},{"date":"2025-02-21","current":-1.524166,"twenty":-2.640045,"median":-1.616517,"eighty":27.578237,"marketCap":265214005},{"date":"2025-02-28","current":-1.485334,"twenty":-2.639942,"median":-1.616392,"eighty":27.458272,"marketCap":258456960},{"date":"2025-03-07","current":-1.523743,"twenty":-2.639942,"median":-1.616392,"eighty":27.391553,"marketCap":256575537},{"date":"2025-03-14","current":-1.554218,"twenty":-2.639942,"median":-1.609231,"eighty":27.345272,"marketCap":261707047},{"date":"2025-03-21","current":-1.599931,"twenty":-2.639443,"median":-1.606923,"eighty":27.291868,"marketCap":269404313},{"date":"2025-03-28","current":-1.533902,"twenty":-2.63621,"median":-1.610089,"eighty":27.2705,"marketCap":258286040},{"date":"2025-04-04","current":-1.472952,"twenty":-2.632425,"median":-1.606923,"eighty":27.2436,"marketCap":248023019},{"date":"2025-04-11","current":-1.36629,"twenty":-2.632236,"median":-1.606804,"eighty":27.162898,"marketCap":230062731},{"date":"2025-04-17","current":-1.523743,"twenty":-2.632085,"median":-1.601978,"eighty":27.088921,"marketCap":256575537},{"date":"2025-04-25","current":-1.457715,"twenty":-2.632085,"median":-1.59733,"eighty":27.02167,"marketCap":245457263},{"date":"2025-05-02","current":-1.518664,"twenty":-2.630639,"median":-1.593374,"eighty":26.954418,"marketCap":255720285},{"date":"2025-05-09","current":-1.401844,"twenty":-2.624771,"median":-1.578143,"eighty":26.880441,"marketCap":236049494},{"date":"2025-05-16","current":-1.589032,"twenty":-2.624402,"median":-1.582705,"eighty":26.793014,"marketCap":221650840},{"date":"2025-05-23","current":-1.748548,"twenty":-2.624228,"median":-1.589772,"eighty":26.719038,"marketCap":243901503},{"date":"2025-05-30","current":-1.809901,"twenty":-2.624228,"median":-1.59733,"eighty":26.530733,"marketCap":252459451},{"date":"2025-06-06","current":-1.957147,"twenty":-2.619619,"median":-1.600881,"eighty":26.362604,"marketCap":272998525},{"date":"2025-06-13","current":-1.969418,"twenty":-2.619619,"median":-1.606684,"eighty":26.295353,"marketCap":274710114},{"date":"2025-06-20","current":-1.969418,"twenty":-2.617702,"median":-1.606923,"eighty":26.133949,"marketCap":274710114},{"date":"2025-06-27","current":-2.165746,"twenty":-2.617223,"median":-1.608506,"eighty":26.093598,"marketCap":302095546},{"date":"2025-07-03","current":-2.294586,"twenty":-2.612928,"median":-1.610813,"eighty":25.932194,"marketCap":320067236},{"date":"2025-07-11","current":-2.319127,"twenty":-2.609134,"median":-1.613573,"eighty":25.824592,"marketCap":323490415},{"date":"2025-07-18","current":-2.122799,"twenty":-2.608514,"median":-1.616392,"eighty":25.804416,"marketCap":296104983},{"date":"2025-07-25","current":-2.294586,"twenty":-2.604583,"median":-1.616392,"eighty":25.77079,"marketCap":320067236},{"date":"2025-08-01","current":-2.233234,"twenty":-2.601179,"median":-1.618882,"eighty":25.716989,"marketCap":311509289},{"date":"2025-08-08","current":-2.122799,"twenty":-2.600657,"median":-1.625326,"eighty":25.646281,"marketCap":296104983},{"date":"2025-08-15","current":-2.034555,"twenty":-2.600657,"median":-1.626101,"eighty":25.462248,"marketCap":276957859},{"date":"2025-08-22","current":-2.057874,"twenty":-2.600589,"median":-1.630907,"eighty":25.274577,"marketCap":280132162},{"date":"2025-08-29","current":-2.022896,"twenty":-2.596817,"median":-1.631164,"eighty":25.105673,"marketCap":275370708},{"date":"2025-09-05","current":-1.94128,"twenty":-2.594332,"median":-1.635595,"eighty":24.837088,"marketCap":264260651},{"date":"2025-09-12","current":-1.923791,"twenty":-2.594332,"median":-1.635809,"eighty":24.546813,"marketCap":261879924},{"date":"2025-09-19","current":-1.731412,"twenty":-2.594332,"median":-1.641083,"eighty":24.519912,"marketCap":235691932},{"date":"2025-09-26","current":-1.696434,"twenty":-2.593719,"median":-1.650094,"eighty":24.291257,"marketCap":230930479},{"date":"2025-10-03","current":-1.643967,"twenty":-2.590811,"median":-1.650232,"eighty":23.968449,"marketCap":223788299},{"date":"2025-10-10","current":-1.824687,"twenty":-2.586674,"median":-1.654891,"eighty":23.827221,"marketCap":248389140},{"date":"2025-10-17","current":-1.818857,"twenty":-2.5818,"median":-1.660079,"eighty":23.652367,"marketCap":247595565},{"date":"2025-10-24","current":-1.859665,"twenty":-2.577086,"median":-1.668975,"eighty":23.450612,"marketCap":253150594},{"date":"2025-10-31","current":-1.906302,"twenty":-2.554019,"median":-1.669282,"eighty":23.329559,"marketCap":259499198},{"date":"2025-11-07","current":-1.894643,"twenty":-2.538713,"median":-1.669282,"eighty":23.329559,"marketCap":257912047},{"date":"2025-11-14","current":-1.756213,"twenty":-2.525658,"median":-1.669282,"eighty":23.329559,"marketCap":239067995},{"date":"2025-11-21","current":-1.594153,"twenty":-2.501339,"median":-1.660079,"eighty":23.329559,"marketCap":234380388},{"date":"2025-11-28","current":-1.647292,"twenty":-2.498516,"median":-1.650371,"eighty":23.329559,"marketCap":242193067},{"date":"2025-12-05","current":-1.641978,"twenty":-2.480029,"median":-1.645298,"eighty":23.329559,"marketCap":241411799},{"date":"2025-12-12","current":-1.695116,"twenty":-2.476229,"median":-1.645298,"eighty":23.329559,"marketCap":249224479},{"date":"2025-12-19","current":-1.663233,"twenty":-2.467015,"median":-1.645298,"eighty":23.329559,"marketCap":244536871},{"date":"2025-12-26","current":-1.923612,"twenty":-2.454351,"median":-1.645298,"eighty":23.329559,"marketCap":282819001},{"date":"2026-01-02","current":-1.897042,"twenty":-2.442325,"median":-1.645298,"eighty":23.329559,"marketCap":278912661},{"date":"2026-01-09","current":-1.918298,"twenty":-2.434588,"median":-1.645298,"eighty":23.329559,"marketCap":282037733},{"date":"2026-01-16","current":-1.827962,"twenty":-2.414644,"median":-1.645298,"eighty":23.329559,"marketCap":268756178},{"date":"2026-01-23","current":-1.939553,"twenty":-2.408949,"median":-1.645298,"eighty":23.329559,"marketCap":285162805},{"date":"2026-01-30","current":-2.077713,"twenty":-2.397973,"median":-1.645298,"eighty":23.329559,"marketCap":305475772},{"date":"2026-02-06","current":-2.136165,"twenty":-2.385456,"median":-1.645298,"eighty":23.329559,"marketCap":314069719}],"updateTime":1770484255234},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVIR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603962550","title":"Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Atea Pharmaceuticals (AVIR) and Penumbra (PEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603962550","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603962550?lang=en_us&edition=fundamental","pubTime":"2026-01-16 18:12","pubTimestamp":1768558348,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Boston Scientific (BSX – Research Report), Atea Pharmaceuticals (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-atea-pharmaceuticals-avir-and-penumbra-pen-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-atea-pharmaceuticals-avir-and-penumbra-pen-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","LU0011850046.USD","LU1718418525.SGD","LU2506951958.HKD","SGXZ57979304.SGD","LU2244417387.USD","BK4588","BK4137","AVIR","HCSG","XBI","SG9999001176.USD","LU0345769128.USD","SG9999001176.SGD","LU1804176565.USD","LU1989764748.USD","LU2112291526.USD","LU2265009873.SGD","LU2087625088.SGD","BK4585","LU1291159041.SGD","LU2491050154.USD","LU0353189680.USD","LU0048584097.USD","LU0266013472.USD","LU0528227936.USD","LABU","LU0077335932.USD","LU0267386448.USD","LU1548497426.USD","LU1791710400.SGD","LU0823417653.USD","LU0432979614.USD","LU2242649171.HKD","LU2491050071.SGD","LU1023059063.AUD","IE0002141913.USD","LU0029874061.USD","LU0238689110.USD","IE00BFTCPJ56.SGD","BSX","LU2362540622.SGD","LU2491049909.HKD","LU2506952170.USD","XLV","LU1153585028.USD","LU0122379950.USD","LU1989772840.SGD","BK4548","PEN"],"gpt_icon":0},{"id":"2603920983","title":"Atea Pharmaceuticals Unveils Antiviral Pipeline Progress and Phase 3 HCV Trial Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2603920983","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603920983?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:56","pubTimestamp":1768485387,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc. provided an update on its focused antiviral pipeline at the 44th Annual J.P. Morgan Healthcare Conference. The company highlighted progress with its fixed-dose combination of bemnifosbuvir  and ruzasvir  for hepatitis C virus , noting completion of enrollment for the Phase 3 C-BEYOND trial in the US and Canada, with results expected in mid-2026. Full patient enrollment for the Phase 3 C-FORWARD trial outside North America is also anticipated by mid-2026, with results expected by year-end 2026. Atea reported cash and investments of $301.8 million as of December 31, 2025, and anticipates a cash runway through 2027. The company also announced plans to initiate a Phase 1 trial of its nucleotide prodrug AT-587 for hepatitis E virus  in mid-2026. Market insights from healthcare professionals underscore the need for shorter, easier-to-use HCV regimens to support rapid test-and-treat models. You can access the full presentation through the link below.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDLHXwd9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2601366416","title":"Atea Pharmaceuticals Outlines 2026 Strategy with Planned Phase 3 HCV Readouts, Initiation of HEV Phase 1 Trial, and Evaluation of Global Commercialization Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366416","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366416?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873651,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Outlines 2026 Strategy with Planned Phase 3 HCV Readouts, Initiation of HEV Phase 1 Trial, and Evaluation of Global Commercialization Options. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atea Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDLbLBtXJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4112","IE00BGHQF748.EUR","NDAQ","BK4585","LU2210150020.SGD","SG9999014005.SGD","BK4588","AVIR","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4007","LU2095319765.USD"],"gpt_icon":0},{"id":"2601036649","title":"Atea Pharmaceuticals Presents 2026 Strategic Priorities at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601036649","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601036649?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873617,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc. presented its 2026 strategic priorities at the 44th Annual J.P. Morgan Healthcare Conference, held January 12-15 in San Francisco. During the event, the company provided updates on its global Phase 3 program for Hepatitis C virus  treatment and its Hepatitis E virus  clinical program, as well as its financial outlook and pipeline diversification strategy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atea Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL74H6zh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4007","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","BK4588","AVIR","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4585","SG9999014021.USD"],"gpt_icon":0},{"id":"2601366113","title":"Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44TH Annual J.p. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366113","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366113?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA6K9YQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2593048262","title":"Atea Pharmaceuticals Completes Patient Enrollment In North American Phase 3 Trial Evaluating Regimen Of Bemnifosbuvir And Ruzasvir For Treatment Of Hepatitis C Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2593048262","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593048262?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:15","pubTimestamp":1766405710,"startTime":"0","endTime":"0","summary":"Dec 22 (Reuters) - Atea Pharmaceuticals Inc ::*ATEA PHARMACEUTICALS COMPLETES PATIENT ENROLLMENT IN NORTH AMERICAN PHASE 3 TRIAL EVALUATING REGIMEN OF BEMNIFOSBUVIR AND RUZASVIR FOR TREATMENT OF HEPAT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nRSDc0QYJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2593248471","title":"Atea Pharmaceuticals Completes Enrollment in Phase 3 HCV Trial of Bemnifosbuvir and Ruzasvir","url":"https://stock-news.laohu8.com/highlight/detail?id=2593248471","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593248471?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:00","pubTimestamp":1766404843,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc. has completed enrollment of more than 880 treatment-nave patients in its C-BEYOND Phase 3 trial, which is evaluating the fixed-dose combination regimen of bemnifosbuvir and ruzasvir compared to sofosbuvir and velpatasvir for the treatment of hepatitis C virus . The C-BEYOND trial is being conducted at approximately 120 clinical sites across the US and Canada. Topline results from this study are expected to be reported in mid-2026. Additionally, the company is advancing the C-FORWARD Phase 3 trial, evaluating the same combination regimen in up to 17 countries outside North America. Enrollment completion for C-FORWARD is anticipated by mid-2026, with topline results expected by year-end 2026. In both studies, bemnifosbuvir and ruzasvir are administered orally once daily for 8 weeks  or 12 weeks , while the comparator regimen is given for 12 weeks. Results have not yet been presented.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL25l8NB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR","AVIR","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014021.USD","BK4007","LU0314104364.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4585","LU2095319765.USD","BK4588","SG9999014013.SGD","NDAQ"],"gpt_icon":0},{"id":"2593847724","title":"Atea Pharmaceuticals Inc - C-Beyond Topline Results Expected Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2593847724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593847724?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:00","pubTimestamp":1766404800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUA9YJNJB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2593484031","title":"Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2593484031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593484031?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:00","pubTimestamp":1766404800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUA9YJNJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2592294880","title":"Nano Dimension And 2 Other Penny Stocks With Promising Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2592294880","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592294880?lang=en_us&edition=fundamental","pubTime":"2025-12-18 01:05","pubTimestamp":1765991108,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a pullback, with major indices like the Dow Jones and S&P 500 facing consecutive losses amid tech sector concerns, investors are increasingly looking for opportunities outside the mainstream. Penny stocks, though often overlooked, continue to present intriguing possibilities for those willing to explore smaller or newer companies that could offer unique growth potential. In this article, we will examine three penny stocks that stand out due to their...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avir/atea-pharmaceuticals/news/nano-dimension-and-2-other-penny-stocks-with-promising-poten","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avir/atea-pharmaceuticals/news/nano-dimension-and-2-other-penny-stocks-with-promising-poten","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AVIR","BK4531","BABB","BK4209","BK4170","BK4505","BK4526","BK4161","BK4509","BK4077","BK4173","LU1235295612.USD","CINT","EGY.AU","LU0049112450.USD","BK4213","WDH","BK4539","BK4551","BK7023","LCUT","BK4113","BK4180","LX","BK4546","BK4166","BK4007","PERF","EGY","BK4023","DDL","LU1046422090.SGD","NNDM","BK4579","TUYA","BK4134","TRUE"],"gpt_icon":0},{"id":"2584945635","title":"Atea Pharmaceuticals to Present at Evercore Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584945635","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584945635?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:00","pubTimestamp":1763553613,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on oral antiviral therapeutics, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 3, 2025, in Coral Gables, Florida. The presentation will feature CEO Jean-Pierre Sommadossi and other members of the management team.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atea Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on November 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL22mMSt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","IE00B64PRP62.GBP","LU2210149790.SGD","BK4585","IE00BGHQF748.EUR","BK4112","IE00BKPKM429.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","BK4007","NDAQ","LU2095319765.USD","BK4588"],"gpt_icon":0},{"id":"2583560890","title":"3 Promising Penny Stocks With Market Caps As Low As $200M","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560890","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560890?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:05","pubTimestamp":1763031911,"startTime":"0","endTime":"0","summary":"As the Dow Jones Industrial Average reaches new heights, closing above 48,000 for the first time amid optimism about an end to the U.S. government shutdown, investors are keenly observing market dynamics that may influence their portfolios. Penny stocks, though a term from earlier market days, remain relevant as they often represent smaller or less-established companies with potential value. By focusing on those with strong financials and clear growth prospects, investors can uncover...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eras/erasca/news/3-promising-penny-stocks-with-market-caps-as-low-as-200m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eras/erasca/news/3-promising-penny-stocks-with-market-caps-as-low-as-200m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4551","WDH","BK4180","ERAS","BK4007","BK4166","LU0049112450.USD","LCUT","DDL","BK4539","BABB","BK4191","AVIR","BK4139","LX","BK4173","BK4076","BK4209","BK4531","BK4579","CRCT","BK4113","BK4021","BK4157","BK4503","LU1046422090.SGD","LDI","PSHG","RERE","BK4509","BK4229","BK4195","BK4122","LU1235295612.USD","UUU"],"gpt_icon":0},{"id":"2583346534","title":"Atea Pharmaceuticals Advances Antiviral Programs with New Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2583346534","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583346534?lang=en_us&edition=fundamental","pubTime":"2025-11-13 12:06","pubTimestamp":1763006794,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals, Inc. ( ($AVIR) ) has released its Q3 earnings. Here is a breakdown of the information Atea Pharmaceuticals, Inc. presented to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/atea-pharmaceuticals-advances-antiviral-programs-with-new-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/atea-pharmaceuticals-advances-antiviral-programs-with-new-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2583583392","title":"Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Announces Progress in Hepatitis C and E Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2583583392","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583583392?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:18","pubTimestamp":1762982314,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atea Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL5VJF9W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2583586386","title":"Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583586386","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583586386?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:05","pubTimestamp":1762981500,"startTime":"0","endTime":"0","summary":"Patient Enrollment on Track in Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV), Topline Results from North America Trial Expected Mid-2026 New Data Show Bemnifosbuvir Has Unique Dual M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186782/0/en/Atea-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOL","AVIR","HSCT","BK4007"],"gpt_icon":0},{"id":"2581883941","title":"Atea Pharmaceuticals announces presentation of data on BEM, RZR","url":"https://stock-news.laohu8.com/highlight/detail?id=2581883941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581883941?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:10","pubTimestamp":1762521051,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals (AVIR) announced the presentation of new modeling data predicting that the Company’s combination regimen of bemnifosbuvir, BEM...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-announces-presentation-of-data-on-bem-rzr-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-announces-presentation-of-data-on-bem-rzr-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2581888246","title":"Atea Pharmaceuticals Unveils Promising Phase 2 Data for Bemnifosbuvir and Ruzasvir Hepatitis C Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888246","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581888246?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:00","pubTimestamp":1762520438,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc. has announced new modeling data supporting its fixed-dose combination regimen of bemnifosbuvir  and ruzasvir  for the treatment of hepatitis C virus  infection. The data predict that the BEM and RZR combination can achieve near-complete inhibition of viral replication, with a modeled time to cure of approximately 7 to 8 weeks. These findings reinforce Phase 2 study results, which showed sustained virologic response rates at 12 weeks post-treatment  of 98% in the per-protocol treatment-adherent population and 95% in all patients regardless of adherence after 8 weeks of treatment. The new data were presented at The Liver Meeting 2025, held by the American Association for the Study of Liver Diseases  from November 7-11, 2025, in Washington, DC. The company is currently using the fixed-dose combination in an ongoing Phase 3 program.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDLr7pms:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4588","LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","LU2210149790.SGD","LU0314104364.USD","BK4007","BK4585"],"gpt_icon":0},{"id":"2581814721","title":"Atea Pharmaceuticals Inc. to Report Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581814721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581814721?lang=en_us&edition=fundamental","pubTime":"2025-11-05 20:00","pubTimestamp":1762344031,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc. will report its third quarter 2025 financial results on November 12, 2025. The results will be released in the \"Events and Presentations\" section of the Investor Relations area of the Atea Pharmaceuticals website at ir.ateapharma.com. A live conference call and audio webcast will be hosted on the same day at 4:30 p.m. ET. Participants may register at the provided link, and an audio webcast archive will be available on the website for at least 90 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atea Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on November 05, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL6555bz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","AVIR","IE00BKPKM429.USD","BK4588","LU0314104364.USD","LU2210149790.SGD","LU2095319765.USD","NDAQ","IE00B64PRP62.GBP","BK4112","BK4585","IE00BGHQF748.EUR","BK4007","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2580022734","title":"Atea Pharmaceuticals Inc  expected to post a loss of 44 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580022734","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580022734?lang=en_us&edition=fundamental","pubTime":"2025-11-04 07:51","pubTimestamp":1762213878,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc  expected to post a loss of44cents a share - Earnings Preview Atea Pharmaceuticals Inc AVIR.OQ AVIR.O is expected to  show no change in quarterly revenue when it reports  resu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF2QF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2577365391","title":"Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2577365391","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577365391?lang=en_us&edition=fundamental","pubTime":"2025-10-22 19:00","pubTimestamp":1761130800,"startTime":"0","endTime":"0","summary":"BOSTON, Oct.  22, 2025  (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral ant","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/22/3170954/0/en/Atea-Pharmaceuticals-to-Host-Virtual-HCV-KOL-Panel-Event-on-November-13-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","KOL","BK4007","BK4181","BK4218","BK4585","HST","BK4588","SOF"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}